Clinical Genetic Testing for Parkinson’s Disease: Why, When and How? Enabling Genetically Targeted Therapeutics in Parkinson’s Disease

Add to Calendar Clinical Genetic Testing for Parkinson’s Disease: Why, When and How? Enabling Genetically Targeted Therapeutics in Parkinson’s Disease 2/25/2021 5:00:00 PM 2/25/2021 7:00:00 PM America/Mexico_City Virtual false MM/DD/YYYY


Date & Location
Thursday, February 25, 2021, 5:00 PM - 7:00 PM

Target Audience
Specialties - Academic/Research, Genetic Counseling, Neurology, Nurse Practitioner, Nursing

Overview

Covers the current understanding of the role of the lysosomal pathway in pathogenesis of sporadic and genetic forms of PD, review the genetically targeted clinical trials and discuss mechanisms for genotyping of PD patients, as well as the role of genetic counseling.



Objectives
  1. Discuss the most common types of PD related genetic mutations.
  2. Explain how to counsel patients with PD regarding genetic testing.

Registration
There is no fee to attend but registration is required. Please register here. 

Accreditation

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Credits
AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Attendance (2.00 hours)